13:37:40 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



Veritas Pharma Inc
Symbol VRT
Shares Issued 38,714,590
Close 2017-07-24 C$ 0.36
Market Cap C$ 13,937,252
Recent Sedar Documents

Veritas Pharma appoints Doig to advisory board

2017-07-24 18:52 ET - News Release

Dr. Lui Franciosi reports

VERITAS PHARMA'S APPOINTS ACCLAIMED AGROLOGIST AND CANNABIS GROWER ON THE ADVISORY

Veritas Pharma Inc . has appointed Peter Doig to the advisory board of Veritas Pharma.

Mr. Doig is a professional agrologist with over 18 years of experience in compost bioengineering, organic soils and fertilizers, biochemistry, microbiology, and agricultural production. For the past 12 years, Mr. Doig has consulted and worked in professional greenhouses, as well as several Health Canada licensed producers and applicants. He has overseen and written standards for certified organic greenhouse production of fruits and vegetables as well as the only Canadian standards that are specific to cannabis cultivation. Mr. Doig joins the advisory board as an expert in cultivation and regulatory compliance.

Veritas chief executive officer Dr. Lui Franciosi commented, "Mr. Doig's experience and knowledge will be extremely valuable as we navigate through the final processes of [Access to Cannabis for Medical Purposes Regulations] application and develop our plans for our cannabis cultivation plant."

About Veritas Pharma Inc.

Veritas Pharma is an emerging-stage pharmaceutical and intellectual property development company, which, through Cannevert Therapeutics Ltd. (CTL), is advancing the science behind medical cannabis. It is the company's aim, through its investment in CTL, to develop the most effective cannabis strains (cultivars) specific to pain, nausea, epilepsy and posttraumatic stress disorder, solving the critical need for clinical data to support medical marijuana claims.

© 2024 Canjex Publishing Ltd. All rights reserved.